• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

FDA To Discuss NADH for ME/CFS at May 8 Meeting

Gemini

Senior Member
Messages
1,176
Location
East Coast USA

Gemini

Senior Member
Messages
1,176
Location
East Coast USA
On May 8, 2017, FDA’s Pharmacy Compounding Advisory Committee will discuss six bulk drug substances nominated for inclusion on the section 503A Bulks List.

May 8-9, 2017 Meeting of the Pharmacy Compounding Advisory Committee (PCAC) - Webcast Information

The Center for Drug Evaluation and Research (CDER) plans to provide a free of charge, live webcast of the May 8-9, 2017, meeting of the Pharmacy Compounding Advisory Committee.

The webcast will not display until the meeting begins at approximately 8:30 a.m. EST on May 8-9, 2017.

Webcasts of advisory committee meetings provided by CDER have limited capacity. Once capacity of the webcast is reached, no additional individuals will have access to the webcast unless others have exited the webcast. If an individual signs off from the webcast, CDER cannot guarantee that this person will be able to sign back on if capacity has been reached.

The meeting webcast can be accessed at the following web address:

https://collaboration.fda.gov/pcac0517/

Note: At the access page, please sign in as a guest. No password is required.
 

keenly

Senior Member
Messages
814
Location
UK
On May 8, 2017, FDA’s Pharmacy Compounding Advisory Committee will discuss six bulk drug substances nominated for inclusion on the section 503A Bulks List.

One these substances, nicotinamide adenine dinucleotide disodium reduced (NADH), has been nominated for reducing symptoms of fatigue in ME/CFS.

Additional information can be found at the following web link:

https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/ucm553328.htm

NOT good news.

FDA is owned by Big Pharma. They need to stay away.
 

RogerBlack

Senior Member
Messages
902
My understanding is that this would make it possible for licenced pharmacists to use NADH in pills they make.
It doesn't have any other regulatory impact - is this correct?

https://www.fda.gov/AdvisoryCommitt...acyCompoundingAdvisoryCommittee/ucm553365.htm - page 54 'the agency is against including NADH on the list'. (for several reasons including lack of proven efficacy and chemical instability if you simply add it to a capsule along with other stuff)

There is also a proposal for Q10, which is similarly recommended against.
 

RogerBlack

Senior Member
Messages
902
Should I go and buy some NADH? CAN I go and buy some NADH?
My understanding (please correct me if I'm wrong) is that this has precisely zero effect on anyones practices at the moment.
It does not prohibit supplements with the compound in question.
It doesn't do anything to change clinical trials, or the approval for them.

It means that if a doctor wanted to prescribe (for example) NADH+Q10+Kryptonite in one pill, they could ask their compounding pharmacy to make some up, and they could, without issue.

At the moment, the compounding pharmacy cannot do this, and the patient would need to take them in separate pills. (or pills found as supplements)
http://www.pccarx.com/what-is-compounding
 

Gemini

Senior Member
Messages
1,176
Location
East Coast USA
My understanding is that this would make it possible for licenced pharmacists to use NADH in pills they make.It doesn't have any other regulatory impact - is this correct?

Some of my takeaways from the meeting's one-hour "NADH for ME/CFS" segment:

The Advisory Committee's decision does not impact the ability to make/buy NADH supplements.

Fagron, a pharmaceutical compounding company, put forth the proposal.

The Advisory Committee, in an unanimous 9-0 vote, upheld the FDA's position against the proposal.

Cited reasons for the rejection-- more studies of the use of NADH in ME/CFS are needed along with more information about its safety and stability.

CDC's Dr. Unger, a member of the Committee, pointed out that some ME/CFS clinicians are currently using NADH in
conjunction with other supplements.
 

HowToEscape?

Senior Member
Messages
626
NOT good news.

FDA is owned by Big Pharma. They need to stay away.

Sure, I'd rather buy my stuff from scam artists who have 27 different company names used to package 'health and nutrition supplements' made from bulk supplies sourced from China.

How about some Ayurvedic magic meds with natural Earth sourced lead? Ayurevedic lead is good for you, it has polarizing energy. Or maybe a Hulda Clark Zapper. That cures everything, but teh evil FDA doesn't want you to know!!!!
 

RogerBlack

Senior Member
Messages
902
Quite.
https://www.alibaba.com/product-detail/high-quality-natural-fermentation-coenzyme-q10_524398846.html - as one example.
This is one kilogram of Q10.
Compared with https://www.naturesbest.co.uk/co-q10-200mg-p730/

$300/kg, vs $1200/kg.
The tests in the first one appear legit, and if they are performed on every batch, with attention to what the impurities actually are, are a reasonable first step. How many US based small companies will verify those tests, when doing that costs several hundred dollars.
How many might go to a cheaper supplier offering 'cosmetic grade'.

Are the impurities harmless antioxidants, or fungal toxins from improperly treated and monitored bioreactor contamination.

The unregulated supplements industry is great, in that it can provide access to things that are simply unavailable conventionally.
But it's got major issues.
 

Learner1

Senior Member
Messages
6,305
Location
Pacific Northwest
Some of my takeaways from the meeting's one-hour "NADH for ME/CFS" segment:

The Advisory Committee's decision does not impact the ability to make/buy NADH supplements.

Fagron, a pharmaceutical compounding company, put forth the proposal.

The Advisory Committee, in an unanimous 9-0 vote, upheld the FDA's position against the proposal.

Cited reasons for the rejection-- more studies of the use of NADH in ME/CFS are needed along with more information about its safety and stability.

CDC's Dr. Unger, a member of the Committee, pointed out that some ME/CFS clinicians are currently using NADH in
conjunction with other supplements.
Do you have any info on the other substances discussed at the meeting, like NAD, ubiquinol, and artemisinin, all of which have utility for ME/CFS, and all of them the FDA recommended against?
 

Learner1

Senior Member
Messages
6,305
Location
Pacific Northwest
This is concerning. The FDA banned DCA which was discussed at the same meeting, which may be helpful in ME/CFS and has been helpful with certain types of cancer.

They are looking to ban glutathione, which my ME/CFS specialist recommended yesterday and the ccommittee recommended against allowing NAD+ which a few of us are benefiting from.

I live on the west coast and know very little about the workings of the FDA. I talked to a rep 3 weeks ago about my concerns with their review of 503b compounds, and put in a written request for info on the process, based in my conversation with the rep, but have heard nothing.

They are not considering needs of ME/CFS patients and we are at risk of losing helpful treatments.

Does anyone know how can we get better information on this process so we patients can give input before we lose treatments?
 

Attachments

  • FDA Compounding Advisory Committee - May 2017.pdf
    7.1 MB · Views: 5
  • FDA interim guidance on 503b .pdf
    111.6 KB · Views: 5
  • fda 503b cat 1 substances.pdf
    439.3 KB · Views: 7